Amerisource­Ber­gen throws down near­ly $1.3B cash for Ger­man life sci­ences com­pa­ny

Amerisource­Ber­gen earned a whop­ping $60.1 bil­lion last quar­ter, thanks in part to its dis­tri­b­u­tion of gov­ern­ment-owned Covid treat­ments. Now it’s time to rein­vest some of that cash.

The phar­ma­ceu­ti­cal dis­trib­u­tor is plunk­ing down $1.28 bil­lion to ac­quire Phar­maLex, a Ger­man life sci­ences com­pa­ny that boasts a range of con­sult­ing and sup­port ser­vices from clin­i­cal de­vel­op­ment to post-launch, the com­pa­nies an­nounced on Mon­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER